Hypericin

[email protected]
Hypericin
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2000-08-03 00:00:00
Sponsor HyBiopharma, Inc.;2500 York Road, Suite 100;Jamison, Pennsylvania, 18929
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM